CCCC Stock Summary and Trading Ideas (C4 Therapeutics | NASDAQ:CCCC)

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

C4 Therapeutics trades on the NASDAQ stock market under the symbol CCCC.

As of January 13, 2026, CCCC stock price climbed to $2.31 with 1,712,099 million shares trading.

CCCC has a beta of 2.45, meaning it tends to be more sensitive to market movements. CCCC has a correlation of 0.20 to the broad based SPY ETF.

CCCC has a market cap of $214.98 million. This is considered a Small Cap stock.

Last quarter C4 Therapeutics reported $11 million in Revenue and -$.44 earnings per share. This beat revenue expectation by $5 million and missed earnings estimates by -$.02.

In the last 3 years, CCCC traded as high as $11.88 and as low as $1.06.

The top ETF exchange traded funds that CCCC belongs to (by Net Assets): VTI, VXF, IBB, SCHA, PRFZ.

CCCC has underperformed the market in the last year with a return of -37.0%, while the SPY ETF gained +20.8%. In the last 3 month period, CCCC fell short of the market, returning +2.7%, while SPY returned +6.5%. However, in the most recent 2 weeks CCCC has outperformed the stock market by returning +13.8%, while SPY returned +0.9%.

CCCC support price is $2.03 and resistance is $2.23 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CCCC shares will trade within this expected range on the day.